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The virus plaque assay has been developed as a tool for enumerating activated lymphocytes.
In previous studies using mitogens it was found that the assay detects activated T-but not activated B-lymphocytes.
In the present studies, the mixed lymphocyte reaction was studied by the virus plaque assay as well as by incorporation of thymidine and development of cytotoxic lymphocytes. In combinations differing at the entire major histocompatibility complex, approximately 1% of the cells were activated and treatment with anti-thy.1 serum totally abrogated the virus plaque forming cell (V-PFC)
response. In studies on the A.TH-A.TL recombinants and the AQR-BlO/ 6R recombinant strains, incompatibility at the H-2-K or H-2-D loci were found not to be capable of activating T-cells to produce virus plaques. In contrast, differences in I or I plus S regions caused a marked T-cell activation, 3-6s of the cells being V-PFC.
There was a general parallelism between thymidine incorporation and the V-PFC, and it was not possible to dissociate the cell types carrying out each of these functions by kinetic studies. However, preinfection of responding cells with the virus used in these studies, vesicular stomatitis virus, caused a complete abrogation of thymidine incorporation, indicating that the activation of virus is an earler stage than DNA synthesis, and that viral activation will block further ccl1 replicaton and is probably a lytic event.
INTRODUCTION
The mixed lymphocyte and graft-versus-host reactions are unique among immunologic reactions in that a very high response is obtained with unimmunized cells, which is apparently not increased after repeated immunization. The frequency of cells responding to foreign histocompatibility antigens has been estimated to be as high as l-376 (l-5). In addition, the mixed lymphocyte reaction (MLR) stimulates several parameters of allograft rejection ; blast cell transformation and thymidine incorporation being regarded as a recognition phase and lymphocytemediated cytotoxicity serving as the effector phase.
As recombinant mouse strain combinations became available, it has been possible to test the importance of different H-2 regions in MLR both for stimulation of the recognition function and as target determinants for cell-mediated cytolysis (6) (7) (8) (9) .
In these studies, it has been shown that I-region differences give strong MLC stimulation, whereas K or D region differences give very weak, if any, MLC stimulation. In contrast, however, K and D region differences serve as target determinants for destruction of cells bearing them by lymphocytes activated by stimulating cells differing at I region plus K or D loci. However, target cells from strains differing solely in I region genes either are not, or only poorly killed by lymphocytes responding solely to products of this region, A virus plaque assay has been developed for estimating the number of activated thymus-derived lymphocytes. It is based on the observation that unstimulated small lymphocytes do not support the replication of RNA viruses, whereas, antigen or mitogen stimulated lymphocytes acquire the capacity to do so (10) (11) (12) . In previous studies of activation of mouse spleen cells by mitogens, it was found that concanavalin A (Con A), phytohemagglutinin (PHA), and pokeweed mitogen were highly effective at stimulating virus plaque forming cells (12) . As many as 6-10% of the spleen cells stimulated with Con A were capable of producing virus, and all of these were found to be T-cells since the response could be ablated by treatment with anti-thy.1 serum plus complement. In contrast, while lipopolysaccharide (LPS) was effective in stimulating thymidine incorporation, there was only a very slight increase above background of virus plaque forming cells, indicating that activated B-lymphocytes are probably not measured by this assay. In these studies, MLR between strains congenic at H-2 but differing at the M locus were studied. Killer cells were not seen in this system yet the virus plaque assay appeared not to detect cells activated in this system. Consequently, the present studies were undertaken to explore in greater detail the requirements for production of V-PFC in MLR by utilizing a variety of mouse H-2 recombinant strains.
MATERIALS AND METHODS
Mice. All of the experiments were done with sets of inbred and congenic resistant strains of mice. The H-2 haplotypes of the strains employed and the alleles at the regions of the H-2 complex are given in Table 1 . 
A.TL carries the H-2t1( H-2t1) haplotype,5 derived from recombination between H-2"'( H-2"') ( t s rain A.AL) and H-2" (strain A.SW) (14) . A.TH carries the the H-2t2(H-2t11) haplotype, derived from recombination between H-2" (strain A) and H-2" (strain A.SW) (15) . A.TL and A.TH are identical at H-2K and H-2I> loci, but different at Ir-lA, Ir-lB, and Ss-Slp loci.
AQR carries the H-2s1 H-2r-K1J) haplotype, derived from recombination between H-2q(strain T138) and H-2"( strain Bl0.A). Although AQR is not congenic with BlO, it had undergone a total of four backcrossings to BlO before the line was established by intercrossing and thus carries a considerable portion of the HI0 genome ( 16) . B 1O.T (6R) carries the H-2@ ( I-I-2yms") haplotype derived from recombination between H-2"( strain B1O.A) and H-2q(strain Bl0.G) (17) .
211 and 4R were derived from recombination between H-2*(strain Bl0.A) and H-2b(strain BlO), are indistinguishable from one another at H-2K and H-2D loci ( 16) and differ at Ir-1B locus and by Slp antigen. Skin graft exchanges between them are accepted for at least 40 days.
H(z1) is an H-2 mutant, originally detected in a (C57BL/6 X BALB/c) I;1 hybrid and crossed onto the C57BL/6 background (IS). The mutation occurred in the H-2 complex to the left of Ss-Slp locus, probably in the K region. Extensive immunization failed to produce cytotoxic or hemagglutinating antisera between H( zl) and I36 until recently (19) . Skin grafts were rejected rapidly. , supplemented with heat-inactivated (56°C for 30 min) fetal calf serum (Reheis Chemical Co., Chicago, Ill., Lot No. H72208), 5 ml/100 ml ; penicillin, 100 units/ml ; streptomycin, 100 pg/ml; and L-glutamine, 2 m!U (RPNI 1640, 5% FCS), in Linbro culture dishes (Linbro Chemical Co., New Haven, Corm., FB-lG-24-TC, lh-mm diam), at 37°C in an atmosphere of 5% CO:! in humidified air.
On the fourth day, cells from three or four replicate cultures were collectetl, centrifuged once, resuspended in fresh culture medium and assayed for (3H 1 thymidine incorporation and virus replication.
Assay of t3H] thgmidine incorporation. Two-tenths milliliter of cell suspension recovered from mixed lymphocyte cultures was transferred to microculture plate (IS-FB-96OTC, Linbro Chemical Co., T\'ew Haven, Corm.) and incubated with 2 PCi of ["t-I] thymidine (sp act 2.0 Ci/mmole, New England Nuclear, Boston, Mass.) for 6 hr at 37°C in 5% CO, in humidified air, Triplicate or quatlruplicate cultures were made for each combination. The ctdtures were harvested onto glassfiber filters, washed with saline, precipitated with 5% TCA, and washed with methanol, 1)~ using a semiautomatic multiple sample har\.ester (NASH-IT, Nicrobiological .2ssociates, Bethesda, Md). The glass fiber filters with precipitates were placed in LSC Mini-Vials (Xew England Nuclear, Boston, Jlass.) , dried, dissolved in 4.5 ml of Omnifluor (New England Nuclear, Boston, Mass.) in toluene (4 g/liter), and assayed by liquid scintillation spectrophotometry.
Y&U, plaque assay. Details of the method have been described previously (lO-12) . After viable cell counting by trypan blue exclusion, 1 x lo6 viable lymphocytes were transferred to 12 X 75-mm a Falcon plastic tube, washed once, and resuspended in 0.2 ml of culture medium. The cells were infected with vesicular stomatitis virus (VSV) at a multiplicity of 50 and incubated at 37°C in 5% CO:! in air for 2 hr to permit virus adsorption and penetration. The excess virus was then removed by washing once, and free virus remaining was neutralized with 0.02 ml of inactivated guinea pig anti-VSV serum by incubation for 1 hr at 4°C. The cells were washed three times more and resuspended in 2 ml of Eagle's MEM with 6% fetal calf serum. A 0.2-ml aliquot of VSV-infected cell suspensions was mixed with 1 ml of 1% agar in MEM-6%
FCS and plated on L-cell monolayer in 60-mm Falcon culture dishes. When this layer af agar had solidified, a second 1.5-ml agar layer was added as a nutrient layer. Each cell sample was plated in three log dilutions, and each dilution was plated in duplicate. At the end of plating, cell counts were made in 0.2% trypan blue to determine the number of viable cells actually plated, The plates were incubated at 37°C in 5% COZ in air for 2 days, then vitally stained with neutral red solution (1: 10,000 in phosphate-buffered saline), and the virus plaques were counted. The results were expressed as V-PFC (virus plaque forming cells)/106 cells actually plated or corrected as V-PFC/lOs cells cultured.
Assay of lymphocyte cytotoxicity. P-815 mastocytoma cells (DBA/2, H-2d), and EL-4 lymphoma cells (C57BL/6, H-2b) were used as target cells. They were maintained in Joklik modified MEM spinner medium with 5% fetal calf serum in stationary culture. Target cells (5 X lo6 cells/ml) were labeled with 100 &i of Naa51Cr04 (New England Nuclear, Boston, Mass.) at 37°C in 5% COP in air for 45 min. After three washings they were adjusted to 1 X lo6 viable cells/ml in RPM1 1640-5%FCS.
The cytotoxicity assay was a modification of that described by Cerottini and Brunner (20) . Lymphocytes from mixed lymphocyte cultures were adjusted to a concentration of 5 x lo6 viable cells/ml in RPM1 1640-5% FCS. One-half milliliter of lymphocyte suspension (2.5 x 106) and 0.05 ml of target cell suspension ( 5 x lo*) were incubated in 12 x 75-mm Falcon plastic tubes (lymphocyte: target cell ratio = 50: 1) at 37°C in 5% CO2 in air for 5 hr without rocking.
At the end of the incubation period, 1 ml of RPM1 1640-5s FCS was added to each tube. The cells were mixed well and centrifuged. One milliliter of the supernatant fluid was aspirated and the amount of radioactivity released in the supernatant fluid was determined. Maximum 51Cr release was determined by counting the amount of 51Cr released into supernatant fluid by freezing and thawing 5 X lo4 target cells three times. Spontaneous 51Cr release was determined as an amount of 51Cr released into supernatant fluid by incubating 5 X lo4 target cells in culture medium alone. The results were expressed as a percentage of lysis using the following formula :
Experimental release -spontaneous release maximum -spontaneous release x loo.
All assays were done in triplicate. Anti-thy-l.2 treatment. AKR anti-CBA thymocyte serum was a gift from Dr. M. Howe. Rabbit serum absorbed with EL-4 cells in the presence of EDTA was used as the source of complement (RS) (21 
RESUTzTS
An increase in the number of cells which support the replication of an RXA virus, vesicular stomatitis virus (VW), was found in the mixed lymphocyte culture using combinations of congenic resistant strains, BlO and BlO.D2 ( Table 2) . The virus plaque forming cell (V-PFC) response in the mitogen-activated mouse spleen cell cultures was previously shown to be predominantly, and probably exclusively, a T-cell response (12) . In order to ascertain whether the virus plaque assay also detects activated T-lymphocytes in the RILC, the cells harvested from the MLC on day 4 (5 X 106/m1) were treated with AKK anti-thy-l. a Spleen cells, 5 X 108, were cultured with 5 X lo6 mitomycin C-treated stimulating spleen cells in 2 ml of RPM1 1640 with 5% FCS for 4 days. Viable cells, 1 X 106, from pooled cultures were infected with VSV for the virus plaque assay. Two-tenths-milliliter aliquots of culture were incubated with 2 rCi of C3H]thymidine for 6 hr. b Mean f SE (n = 3). c Mean f SE (n = 4).
that the MLC reaction is predominantly T-cell response and activated T-lymphocytes can be enumerated by the virus plaque assay.
Reladve Importance of Different Regions of the H-2 Complex for V-PFC Response
MLC and the cell-mediated lympholysis (CML) have been regarded as in vitro correlates of the recognition phase and effector phase of the allograft reactions, respectively. Recent studies using recombinant strains within H-Z complex enhanced our knowledge about relative importance of different regions of the H-2 complex for MLC stimulation (7, 8) and generation of the cytotoxic lymphocytes (9) .
As a means to clarify whether the virus plaques assay measures all the activated T-lymphocytes or a subpopulation of the activated lymphocytes such as effector cells, the relative importance of different regions of the H-2 complex for the V-PFC response was studied using sets of recombinant strain combinations.
A representative result of the most informative strain combinations is shown in Table 3 . A.TH and A.TL strains, which are identical at H-2K and H-2D loci, but differ in I and S regions, stimulate strong V-PFC response reciprocally. On the other hand, A.TH spleen cells cultured with A.SW spleen cells (H-2D locus difference), or A.TL spleen cells cultured with A.AL spleen cells (H-2K locus difference) did not give significant V-PFC response above their control syngeneic cultures. Addition of K or D region differences to the I and S region difference did not increase the V-PFC response ( Table 3) .
The importance of the region between H-2K and H-2D for V-PFC response was also demonstrated in another recombinant strain. AQR spleen cells stimulated with 6R cells, which are identical at H-2K and H-2D loci but different in I and S regions, also gave strong V-PFC responses. The same AQR spleen cells cultured with BIO.A cells which are different at H-2K locus gave no significant V-PFC response ( Strains 4R and 2R derived from recombinations of H-2" and H-2" chromosome and are identical at H-2K, H-2D, and I-A loci. 4R spleen cells stimulated with 2R cells showed a significant but relatively weak V-PFC response. Addition of 1) region incompatibility (4R stimulated with BIO.A) increased the magnitude of the V-PFC response. The K and I-A region incompatible combination (4R stimulated with RlO) gave higher V-PFC response than I-B, S, and D region incompatible combination (4R stimulated with BIO.A) ( Table 5) .
H( zl) is congenic with B6, the only known difference being a mutation in the H-2 complex, to the left of Ss-Slp locus, presumably in K. The exact location and extent of the mutation is not clear. B6 and H( zl ) stimulated reciprocally to give a marked lT-PFC response (Table 6 ).
Kinetics of tlzc V-PFC Response in MLC
As another approach to clarify the relationship of the V-PFC response with cell proliferation and development of cytotoxic lymphocytes, their kinetics were compared in the mixed lymphocyte culture. BlO spleen cells cultured with BlO.DZ spleen cells or BlO cells were harvested each day and assayed for virus replication, [3H]thymidine incorporation and cytotoxicity against P-815 mastocytoma (IT-2") target cells (Fig. 1) . The increment of V-PFC or counts per minute in allogeneic culture above syngeneic culture increased apparently exponentially till day 5 and then declined sharply. The ratio of counts per minute in allogeneic cultures to counts per minute in syngeneic culture reached its peak on clay 4 and declined thereafter mainly because of increased background ["H] tl iymitline incorporation in syngeneic culture. Lymphocyte cytotoxicity was very weak on days 2 and 3, rose on day 4, reached its peak on day 5 and remained high. Changes in culture conditions (data not shown) had a significant effect on the kinetics, and the results indicated that the kinetics of all three reactions were similar and not a useful parameter for distinguishing subpopulations. The results of one such experiment is shown in Table 7 . Preinfection with \-SV reduced ["HI thymidine incorporation both in allogeneic combination and in syngeneic combination. Although the allogeneic cultures of preinfected spleen cells usually gave higher [ 3H] thymidine incorporation than syngeneic cultures, the reduction in response by preinfection in terms of 4 cpm per culture \vas greater than 98%. DISCUSSIOS 'IVhen the virus plaque assay (VPA) was applied to MLR involving differences across the entire major histocompatibility complex, a striking increase in virus plaque forming cells was observed, indicating approximately 1% of the cells were activated ( Table 2) . Treatment of the responding cells with anti-thy. 1 serunl and complement totally abrogated the response demonstrating that the cells being detected by the virus plaque assay are indeed T-cells.
Studies on two recombinant strain combinations indicated that stimulation of the V-PFC response by H-2" or H-2d locus incompatibility was insignificant (Tables  3 and 4) . However, I region or I + S region differences led to marked stimulation (3-6s V-PFC). Addition of H-2" or H-2" locus incompatibilities to I and S region differences did not increase the number of responding cells.
Studies on the 4R and 2R recombinants indicated that significant stimulation was obtained in strains differing by I-A and I-B subregions, the former being essentially four times more effective than the latter. In this combination, there was some additive effect when a D end incompatibility was present together with differences at I-B and S. While this result might be suggestive of additional weak MLC determinants coded for by a region between SS and D, because additive effects of D or K end determinants in two other systems were not seen, the result could as well be an idiosyncrasy of the .2R-4R combination.
One anomalous strain combination was studied, namely the B6/Hzl combination, which is believed to be identical to the I, S, and D regions, but to differ from the parent B6 strain by virtue of a mutation in the K region. Recently a serological difference has been detected between these strains ( 19) . In the present studies, a strong activation of T-cells was detected by the VPA, which is consistent with the in viva finding that grafts between these strains are mutually rejected. It thus appears that in terms of genetic determinants governing lymphocyte activation, there were no significant differences between those stimulating thymidine incorporation and those generating V-PFC.
In order to try to distinguish the functional differences between activated lymphocytes measured by thymidine incorporation, cytotoxicity, and the virus plaque assay, a series of kinetic experiments were carried out on the development of each of the functional parameters. Under conditions which optimized the yield of V-PFC and cytotoxic lymphocytes, the peak of all activities was found on day 5 of culture ( Fig. l) , although different culture conditions were found to have a significant effect on the peak responses of the various parameters. We are forced to conclude that it is very difficult to differentiate V-PFC either from thymidine incorporating cells or cytotoxic lymphocytes by means of kinetic studies. One additional difficulty in these studies on mouse lymphocyte cultures has been the variable and low percentage of recovery of viable cells per culture, and it is not known whether there is any selectivity in cell loss for cells carrying out different functions under the different culture conditions.
A comparison of the results with the virus plaque assay with other parameters used to study mixed lymphocyte cultures is given in Table 8 . There appears to be a relative parallelism between the V-PFC response, thymidine incorporation, and graft rejection in z&o. The major discrepancy derives from the experiences in a number of laboratories which have been unable to demonstrate cell-mediated cytotoxicity across determinants coded for solely by the I region. Unfortunately, it is difficult to interpret this observation, because Ia determinants coded for by the I region and detected serologically are usually not detected, or found in only low amounts, on mouse tumor cells and PHA activated blasts, the most common targets for cell-mediated cytolysis. There is some indication that since Ia is expressed in greater amounts on B-lymphocytes, killing across I region differences can be In the usual protocol, lymphocytes are acti\-atetl l)\-;ZlLR, antigen, or mitogen, ant1 then 3 or 5 days later infected with virus and plated for \--PfTC. TIN the experiments described in Table 7 . resting lymphocytes were infected before laming stimulated in an RILR, ant1 the V-PFC and th\niidine incorporation wet-c mv;tsured. Under these conditions in which V-EC are generated, there was an almost total ablation of tliymicline incorporation, and in preliminary studies in genrratiwl of killer ~~lll~~hOCyteS.
It iS SLiggeSted fTOil1 theSe eXp-inKiltS, together With ~Jw\'knlS experiments using mitotic inhibitors, that lymphocyte activation for replication of virus is an early event, and precedes UN,4 synthesis. These data are consistent with the results on synchronized human I\-m~~liol~lastoitl lines indicating that Tit-us replication occurs maximally during ( ;I of the cell cycle (25) . Secondly, since 1-S\ is a lytic virus, activation of preinfected cells to produce virus most likelv leatls to destruction of the activated cells, and thus provides a lwtential strategy for elimiuating histocompatibility antigen-reactive cells. Preliminary experiments carried ollt with Dr. Al. Sowakowski. T. Romano, ant1 J. Thorl~ecl~e (23, 2-F) indicate tll;lt 1)reinfection of allogeneic spleen cells can ahgate their ability to generate q-aftwrsus-host responses upon transfer to iiiimunologicall~ coml~roniisetl recilkits.
